Previous Close | 11.00 |
Open | 11.00 |
Bid | 10.50 |
Ask | 12.10 |
Strike | 40.00 |
Expire Date | 2024-07-19 |
Day's Range | 11.00 - 11.00 |
Contract Range | N/A |
Volume | |
Open Interest | 82 |
Q4 2024 Roivant Sciences Ltd Earnings Call
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.